Research ExplorerPublicationsUpdate Breast Cancer 2018 (Part 2) - Advanced Breast Cancer,...

Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

Standard

Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. / Schneeweiss, Andreas; Lux, Michael P; Janni, Wolfgang; Hartkopf, Andreas D; Nabieva, Naiba; Taran, Florin-Andrei; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Wöckel, Achim; Ettl, Johannes; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W; Belleville, Erik; Wallwiener, Diethelm; Brucker, Sara Y; Schütz, Florian; Fasching, Peter A; Fehm, Tanja N.

In: GEBURTSH FRAUENHEILK, Vol. 78, No. 3, 03.2018, p. 246-259.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schneeweiss, A, Lux, MP, Janni, W, Hartkopf, AD, Nabieva, N, Taran, F-A, Overkamp, F, Kolberg, H-C, Hadji, P, Tesch, H, Wöckel, A, Ettl, J, Lüftner, D, Wallwiener, M, Müller, V, Beckmann, MW, Belleville, E, Wallwiener, D, Brucker, SY, Schütz, F, Fasching, PA & Fehm, TN 2018, 'Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention', GEBURTSH FRAUENHEILK, vol. 78, no. 3, pp. 246-259. https://doi.org/10.1055/s-0044-101614

APA

Schneeweiss, A., Lux, M. P., Janni, W., Hartkopf, A. D., Nabieva, N., Taran, F-A., Overkamp, F., Kolberg, H-C., Hadji, P., Tesch, H., Wöckel, A., Ettl, J., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wallwiener, D., Brucker, S. Y., ... Fehm, T. N. (2018). Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. GEBURTSH FRAUENHEILK, 78(3), 246-259. https://doi.org/10.1055/s-0044-101614

Vancouver

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran F-A et al. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. GEBURTSH FRAUENHEILK. 2018 Mar;78(3):246-259. https://doi.org/10.1055/s-0044-101614

Bibtex

@article{cd2aa92333564f7d832b925ebe2a1f8c,
title = "Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention",
abstract = "The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes play a major role, more and more new therapies for subgroups and histological subtypes are being developed, such as the use of PARP inhibitors to treat patients with BRCA mutations (breast and ovarian cancer). Supportive therapies are also evolving, allowing problems such as alopecia or nausea and vomiting to be treated more effectively. Treatment-related side effects have a direct impact on the prognosis of patients with metastatic breast cancer, and supportive therapy can improve compliance. Digital tools could be useful to establish better patient management systems. This overview provides an insight into recent trials and how the findings could affect routine treatment. Current aspects of breast cancer prevention are also presented.",
keywords = "Journal Article",
author = "Andreas Schneeweiss and Lux, {Michael P} and Wolfgang Janni and Hartkopf, {Andreas D} and Naiba Nabieva and Florin-Andrei Taran and Friedrich Overkamp and Hans-Christian Kolberg and Peyman Hadji and Hans Tesch and Achim W{\"o}ckel and Johannes Ettl and Diana L{\"u}ftner and Markus Wallwiener and Volkmar M{\"u}ller and Beckmann, {Matthias W} and Erik Belleville and Diethelm Wallwiener and Brucker, {Sara Y} and Florian Sch{\"u}tz and Fasching, {Peter A} and Fehm, {Tanja N}",
year = "2018",
month = mar,
doi = "10.1055/s-0044-101614",
language = "English",
volume = "78",
pages = "246--259",
journal = "GEBURTSH FRAUENHEILK",
issn = "0016-5751",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

AU - Schneeweiss, Andreas

AU - Lux, Michael P

AU - Janni, Wolfgang

AU - Hartkopf, Andreas D

AU - Nabieva, Naiba

AU - Taran, Florin-Andrei

AU - Overkamp, Friedrich

AU - Kolberg, Hans-Christian

AU - Hadji, Peyman

AU - Tesch, Hans

AU - Wöckel, Achim

AU - Ettl, Johannes

AU - Lüftner, Diana

AU - Wallwiener, Markus

AU - Müller, Volkmar

AU - Beckmann, Matthias W

AU - Belleville, Erik

AU - Wallwiener, Diethelm

AU - Brucker, Sara Y

AU - Schütz, Florian

AU - Fasching, Peter A

AU - Fehm, Tanja N

PY - 2018/3

Y1 - 2018/3

N2 - The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes play a major role, more and more new therapies for subgroups and histological subtypes are being developed, such as the use of PARP inhibitors to treat patients with BRCA mutations (breast and ovarian cancer). Supportive therapies are also evolving, allowing problems such as alopecia or nausea and vomiting to be treated more effectively. Treatment-related side effects have a direct impact on the prognosis of patients with metastatic breast cancer, and supportive therapy can improve compliance. Digital tools could be useful to establish better patient management systems. This overview provides an insight into recent trials and how the findings could affect routine treatment. Current aspects of breast cancer prevention are also presented.

AB - The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes play a major role, more and more new therapies for subgroups and histological subtypes are being developed, such as the use of PARP inhibitors to treat patients with BRCA mutations (breast and ovarian cancer). Supportive therapies are also evolving, allowing problems such as alopecia or nausea and vomiting to be treated more effectively. Treatment-related side effects have a direct impact on the prognosis of patients with metastatic breast cancer, and supportive therapy can improve compliance. Digital tools could be useful to establish better patient management systems. This overview provides an insight into recent trials and how the findings could affect routine treatment. Current aspects of breast cancer prevention are also presented.

KW - Journal Article

U2 - 10.1055/s-0044-101614

DO - 10.1055/s-0044-101614

M3 - SCORING: Journal article

C2 - 29576630

VL - 78

SP - 246

EP - 259

JO - GEBURTSH FRAUENHEILK

JF - GEBURTSH FRAUENHEILK

SN - 0016-5751

IS - 3

ER -